Medtech company Wenzel Spine received FDA clearance for panaSIa, an expandable sacroiliac fusion implant.
The implant offers a minimally invasive procedure option for patients with sacroiliac joint dysfunction, according to a July 15 news release from Wenzel Spine.
The approval marks the first FDA clearance of an expandable SI fusion implant.
The system separates the joint surfaces and minimizes micro-motion in the joint to provide immediate fixation and stabilize the joint for fusion, the release said.
